Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM)

• Status: Completed
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Is the valproic acid efficacy to treat TSP/HAM

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Sao Paulo
• Treatments: Valproic Acid

Criteria

Inclusion Criteria:

• HTLV-1; TSP/HAM fulfill criteria

Exclusion Criteria:

• Age <18 years